Okazaki O, Kurata T, Tachizawa H
Drug Metabolism Research Center, Daiichi Seiyaku Co., Ltd., Tokyo, Japan.
Chemotherapy. 1988;34(2):149-54. doi: 10.1159/000238562.
Effects of repeated oral administration of new quinolones, ofloxacin, enoxacin and norfloxacin, once daily for 7 days, on the drug-metabolizing enzyme system of rat hepatic microsomes were studied in comparison with that of phenobarbital, a potent inducer of cytochromes P-450. Treatment of phenobarbital at the oral dose of 120 mg/kg induced significant increases in the contents of cytochrome P-450, cytochrome b5 and NADPH-cytochrome P-450 reductase and in the activity of ethoxycoumarin O-deethylase, and significant decreases in the activities of benzphetamine N-demethylase and aniline hydroxylase. However, ofloxacin, enoxacin and norfloxacin at the oral dose levels of 80 and 320 mg/kg showed no significant effect on the content of each constituent of the drug-metabolizing enzyme system, and the three enzyme activities. Thus, it is concluded that new quinolones including ofloxacin have no ability to induce a cytochrome-P-450-dependent monooxygenase system.
将新喹诺酮类药物氧氟沙星、依诺沙星和诺氟沙星每日口服一次,连续7天,研究其对大鼠肝微粒体药物代谢酶系统的影响,并与细胞色素P - 450的强效诱导剂苯巴比妥进行比较。口服剂量为120mg/kg的苯巴比妥处理可使细胞色素P - 450、细胞色素b5和NADPH - 细胞色素P - 450还原酶的含量显著增加,乙氧香豆素O - 脱乙基酶的活性显著增加,而苄非他明N - 脱甲基酶和苯胺羟化酶的活性显著降低。然而,口服剂量为80mg/kg和320mg/kg的氧氟沙星、依诺沙星和诺氟沙星对药物代谢酶系统各成分的含量及三种酶活性均无显著影响。因此,得出结论,包括氧氟沙星在内的新喹诺酮类药物没有诱导细胞色素P - 450依赖性单加氧酶系统的能力。